| Financial Year |
March 31 2023 |
| Monetary Funds |
322,262,913.48 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
140,000.00 |
| Accounts Receivable |
135,320,580.37 |
| Advances to Suppliers |
51,974,803.88 |
| Other Receivables |
19,680,313.76 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
169,806,807.61 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
9,674,510.68 |
| Total Current Assets |
708,859,929.78 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
70,872,304.91 |
| Investment Properties |
-- |
| Fixed Assetes |
343,026,871.74 |
| Under-construction Projects |
6,330,045.66 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
62,685,532.41 |
| R&D expenses |
-- |
| Goodwill |
1,497,957.40 |
| Long-Term Deferred and Prepaid Expenses |
540,830.31 |
| Deferred Income Tax Assets |
8,709,450.76 |
| Other Non-Current Assets |
16,787,990.63 |
| Sub-Total of Non-Current Assets |
511,295,524.90 |
| Total Assets |
1,220,155,454.68 |
| Short-Term Loans |
205,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
127,848,285.27 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
14,879,302.91 |
| Taxes Payable |
1,551,015.27 |
| Interest Payable |
-- |
| Dividend Payable |
10,984,758.25 |
| Other payables |
58,370,645.37 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
813,912.61 |
| Other Current Liabilities |
3,123,911.72 |
| Sub-Total of Current Liabilities |
446,337,552.19 |
| Long-term Loans |
15,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
1,077,342.17 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,931,485.14 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
34,802,658.28 |
| Total Liabilities |
481,140,210.47 |
| Paid-In Capital(Or Share Stock) |
211,332,310.00 |
| Capital Surplus |
620,714,153.04 |
| Surplus Reserve |
21,799,625.95 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-246,140,084.80 |
| Minority Stockholder's Interest |
131,309,240.02 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
607,706,004.19 |
| Owner's Equity（Stockholder's Equity） |
739,015,244.21 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,220,155,454.68 |
